Exploreing the effect of a novel therapy on chronic intrathecal inflammation in patients with active progressive multiple sclerosis (Finalized Research Call 2021, Young Researchers)

Project objectives

The project investigates the neuroinflammatory and neuroresolving course, associated with neurodegeneration, in patients suffering from primary progressive multiple sclerosis, along different stages of the disease and in relation to the use of immunomodulatory drugs as commonly used in the treatment of the disease.

Start and end date

June 2023 – Currently ongoing

Project Manager

The Dr. Leuti is responsible for the second operational unit of the project.

Coordinating institution of the project

Integrated University Hospital – Verona

Other Institutions involved

  • F.S.L.

Funding source(s).

Ministry of Health (Finalized Research Call 2021 – Young Researchers)